Theory as to why CJC DAC interferes with IGF-1 LR3?

[Landmonster]

I have seen in numerous researchers posts that they believe that IGF-1 LR3 interferes with CJC DAC 1295.

First of all, I'd like to determine if this is actually true. If so, I'd like to develop a rudimentary understanding, or at least a "working theory", as to why this is the case.

People say that when they are researching both concurrently, that as soon as the IGF-1 is ceased, then the CJC DAC becomes much more highly effective. This appears to indicate that the IGF interferes with the effectiveness of CJC, more than the CJC interferes with the IGF. These same people still claim good gains from the IGF, while researching both compounds concurrently.

So...

1. So, why do you think the IGF-1 peptide interferes with the effectiveness of the CJC DAC peptide?
2. Does the CJC DAC truly interfere with, or lessen the gains from, IGF-1? Or is there some alternate explanation here?
3. Is it possible that the IGF-1 that interferes with, or lessens the gains from, CJC DAC?
4. How can we circumvent this problem, while still using IGF and GH peptides?
5. Should we rotate them by alternating days? Or months?
6. Should we run a different GH peptide with IGF-1 LR3?

I'm just tossing out questions and ideas.

 

[omegachewy]

I think it has to do with your body combating two mechanisms. Glucose uptake and lipolysis. However, what do you mean by interfere. because cjc is increasing gh, which increases igf 1 levels, sooooo we are simply creating more of the same thing through two different routes, with the lr3 being more specialized (satellite cell differentiation)